Back to Browse Journals » International Journal of Chronic Obstructive Pulmonary Disease » Volume 2 » Issue 3

Factors affecting health status in COPD patients with co-morbid anxiety or depression

Authors Minna J Hynninen, Ståle Pallesen, Inger Hilde Nordhus

Published 15 October 2007 Volume 2007:2(3) Pages 323—328

Minna J Hynninen¹, Ståle Pallesen², Inger Hilde Nordhus¹

¹Department of Clinical Psychology, University of Bergen, Norway ²Department of Psychosocial Science, University of Bergen, Norway

Abstract: Health status questionnaires provide standardized measures of patients’ perceptions of the impact of disease on their daily life and well-being. Factors associated with health status were examined in a sample of 58 outpatients with chronic obstructive pulmonary disease (COPD) and co-morbid anxiety and/or depression. A cross-sectional descriptive study was conducted with the following measures: The St. George’s Respiratory Questionnaire (SGRQ); the Beck Anxiety Inventory (BAI); the Beck Depression Inventory, 2nd edition (BDI); the Pittsburgh Sleep Quality Index (PSQI); and spirometry. Disease severity as measured with spirometry was not related to health status. Perceptions of poor health as implied by the health status scores were positively associated with symptoms of anxiety and depression, sleep disturbances, and level of daily functioning. There were statistically significant differences between men and women on COPD severity, age, and the BAI scores. The findings emphasize the importance of screening the patients at all stages of disease severity for anxiety, depression, and sleeping problems, in order to provide adequate care for these problems.

Keywords: COPD, health status, health-related quality of life, anxiety, depression, sleep

Download Article [PDF] 

Readers of this article also read:

A thorough QT study to assess the effects of tbo-filgrastim on cardiac repolarization in healthy subjects

Adar L, Avisar N, Lammerich A, Kleiman RB, Spiegelstein O

Drug Design, Development and Therapy 2015, 9:2653-2662

Published Date: 15 May 2015

Urine metabolomics in rats after administration of ketamine

Wen C, Zhang M, Ma J, Hu L, Wang X, Lin G

Drug Design, Development and Therapy 2015, 9:717-722

Published Date: 3 February 2015

Competitive inhibition of survivin using a cell-permeable recombinant protein induces cancer-specific apoptosis in colon cancer model

Roy K, Kanwar RK, Krishnakumar S, Cheung CH, Kanwar JR

International Journal of Nanomedicine 2015, 10:1019-1043

Published Date: 2 February 2015

Liver-targeted cyclosporine A-encapsulated poly (lactic-co-glycolic) acid nanoparticles inhibit hepatitis C virus replication

Jyothi KR, Beloor J, Jo A, Nguyen MN, Choi TG, Kim JH, Akter S, Lee SK, Maeng CH, Baik HH, Kang I, Ha J, Kim SS

International Journal of Nanomedicine 2015, 10:903-921

Published Date: 30 January 2015

Heart rate control with adrenergic blockade: Clinical outcomes in cardiovascular medicine

David Feldman, Terry S Elton, Doron M Menachemi, et al

Vascular Health and Risk Management 2010, 6:387-397

Published Date: 24 May 2010

α-L-iduronidase therapy for mucopolysaccharidosis type I

Jakub Tolar, Paul J Orchard

Biologics: Targets and Therapy 2008, 2:743-751

Published Date: 5 December 2008

Health literacy in COPD

Nicola J Roberts, Ramesh Ghiassi, Martyn R Partridge

International Journal of Chronic Obstructive Pulmonary Disease 2008, 3:499-507

Published Date: 5 December 2008

Non-invasive ventilation in exacerbations of COPD

Nicolino Ambrosino, Guido Vagheggini

International Journal of Chronic Obstructive Pulmonary Disease 2007, 2:471-476

Published Date: 15 January 2008